In Situ PROTAC Synthesis Enabled by Pathologically Activated Bioorthogonal Catalysis for Precision Cancer Therapy
Journal of the American Chemical Society · 2025
DOI: 10.1021/jacs.5c15945 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Dilan Ouyang und 9 weiteren Autor:innen. Beteiligte Einrichtung: New Cornerstone Science Laboratory, MOE Key Laboratory for Analytical Science of Food Safety and Biology, College of Chemistry, Fuzhou University, Fu…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Proteolysis, Neoplasms, Precision Medicine. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Science and Technology Projects of Fujian Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- New Cornerstone Science Laboratory, MOE Key Laboratory for Analytical Science of Food Safety and Biology, College of Chemistry, Fuzhou University, Fuzhou 350108, P. R. China.
- Department of Biomedical Engineering, Emory University, 1760 Haygood Drive, NE, Atlanta, Georgia 30322, United States.
- Coulter Department of Biomedical Engineering, Georgia Institute of Technology, 313 Ferst Dr NW, Atlanta, Georgia 30332, United States.
- State Key Laboratory of Biomedical Imaging Science and System, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, P. R. China.
- School of Medicine, Fuzhou University, Fuzhou 350108, P. R. China.
ORCID-Profile: Yuhang Yao, Zhitong Chen, Zhaowei Chen, Huanghao Yang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Science and Technology Projects of Fujian Province
Zitieren
APA
Ouyang, D., Yang, R., Yao, Y., Jiang, F., Song, S., Yang, Y., Ogunnaike, E. A., Chen, Z., Chen, Z., & Yang, H. (2025). In Situ PROTAC Synthesis Enabled by Pathologically Activated Bioorthogonal Catalysis for Precision Cancer Therapy. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c15945
Vancouver
Ouyang D, Yang R, Yao Y, Jiang F, Song S, Yang Y, et al. In Situ PROTAC Synthesis Enabled by Pathologically Activated Bioorthogonal Catalysis for Precision Cancer Therapy. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.5c15945
BibTeX
@article{Ouyang2025,
author = {Ouyang, Dilan and Yang, Rongjin and Yao, Yuhang and Jiang, Fang and Song, Sijie and Yang, Yuheng and Ogunnaike, Edikan A and Chen, Zhitong and Chen, Zhaowei and Yang, Huanghao},
title = {In Situ PROTAC Synthesis Enabled by Pathologically Activated Bioorthogonal Catalysis for Precision Cancer Therapy},
journal = {Journal of the American Chemical Society},
year = {2025},
doi = {10.1021/jacs.5c15945}
}
EUVIMED